TrialDiabetologia2022

Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.

Xiuying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.